Bellamy's Australia Ltd's share price is plunging: Should you sell?

Bellamy's Australia Ltd (ASX:BAL) shares have been swamped. Now what?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Bellamy's Australia Ltd (ASX:BAL) shares have been swamped, falling 43.5% on Friday alone.

Now what?

As always, there are three options:

(1) Sell

For most, the first reaction to Friday's sudden share price fall would have been shock, then panic. Few brokers or analysts in the marketplace saw the fall coming and those that say they did had flimsy investment theses. Indeed, their investment theses appeared to be based more on what 'could happen' than what 'should happen'.

Nonetheless, investing is a game of odds because nothing is certain. And even at today's seemingly discounted price, Bellamy's shares change hands at over 17 times last year's profits per share — and that's before we factor in a potential downgrade to profit margins.

That could prove to be a hefty price to pay for a company that is now also perceived to be lacking in credibility at its highest levels of management.

Here is a rough timeline of events:

  • Late August: Bellamy's Chairman Robert Woolley sold $2.9 million worth of Bellamy's shares (priced at $14.60 each), while CEO Laura McBain sold $2.4 million (priced at $14.55). Admittedly, both (but especially McBain) have material amounts of skin in the game. Moreover, sales for the period to 20 November 2016 had risen 24% compared to the same period a year earlier.
    Unfortunately, sometimes the perception of a lack of credibility is more powerful than the credibility itself. Therefore, if the perception of poor management hangs around for some time, Bellamy's shares are unlikely to be priced as richly as they once were.
  • October: In its annual general meeting (AGM) presentation, Bellamy's said Chinese regulations will strengthen the company's long term growth opportunities.
  • Early December: Finally, the company said a temporary volume dislocation had taken place in China and full-year revenue could be slightly below last year's result, if the trend persists.

(2) Buy

Let's not forget Bellamy's has been the pride and joy of many investors' portfolios since listing in 2014. Here's why:

Source: Google Finance
Source: Google Finance

As you can see, the share price is up more than 380%. Fuelled by strong growth in the Chinese infant formula market for the past two years. Until last week, nearly everyone thought consumers could not get enough.

If (admittedly, it's a big 'if') the Chinese market supply concerns subside over the coming 12 months as a result of new regulation, Bellamy's shareholders could once again be on a ticket upwards.

Basic economics tells us that if a company has been highly successful in a market which has low barriers to entry, new competitors will emerge and prices will fall. If Bellamy's meets the new regulations, it could provide some protection to the wave of new competition flooding the market. Looking further ahead, if the company can return to exponential sales growth, today's share price will likely prove to be very cheap.

(3) Hold

At its recent AGM, Bellamy's competitor a2 Milk Company Ltd (Australia) (ASX: A2M) announced impressive results for the four months to October, including the key market of China.

If Bellamy's upped sales until November and a2 Milk reported strong results to October, is it likely we have witnessed a structural change in the market? I think it is too early to tell.

Foolish takeaway

Looking at it through different lenses may shed more light on the Bellamy's saga moving forward. Personally, I find the 'lack of credibility' argument a moot point (i.e. debatable) because both directors have significant skin in the game. For example, at the time McBain sold her $2.4 million of shares, her entire stake was worth more than $36 million. Therefore, attacking management's credibility for selling shares may be nothing more than pot-shot journalism.

I do not have enough information to stick my neck out and say Bellamy's shares are a buy or a sell at today's prices, so I would probably stay the course until I could say for certain that my investment thesis was wrong. However, if prices fall further, I will all but certainly be running the ruler over them. 

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any company mentioned. Owen welcomes -- and encourages -- your feedback on Google+, LinkedIn or you can follow him on Twitter @ASXinvest. The Motley Fool Australia owns shares of A2 Milk and Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »